One woman's experience with the Alzheimer's drug Leqembi

By Jon Hamilton

Published February 25, 2025 at 4:22 PM CST

Facebook
Twitter
LinkedIn
Email

Sue Bell was one of the first patients to receive the Alzheimer's drug lecanemab in 2020 as part of the clinical trial. It didn't stop the disease.

Tags

Health

Facebook
Twitter
LinkedIn
Email

Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.

Subscribe to our Newsletter

Tuned In is a 'behind the mic' update on all things WLRH. Subscribe and also be the first to find out about special programming and events, station news and more!

Good News Brief

Click here to send us your good news!

Latest Stories from WLRH

StoryCorps- Capturing Huntsville Voices
Caring for your Vocal Instrument with Huntsville Master Chorale's Workshop: "The Evolving Voice"
Chamber Ensemble "What is Noise" Brings New Music to New Ears
KJ Impact Foundation to Host Wellness Extravaganza

WLRH is hiring!

WLRH is seeking a part-time radio producer with experience in broadcasting, podcasting, or print media. Apply online or by mail by February 27th; no phone calls or station visits, please.